Literature DB >> 15756642

Kinetics of costimulatory molecule expression by T cells and dendritic cells during the induction of tolerance versus immunity in vivo.

Kristin Hochweller1, Stephen M Anderton.   

Abstract

Steady-state dendritic cells (DC) present peptide-MHC complexes to T cells in a tolerogenic manner, presumably because of deficient costimulation. However, it is clear that the path to tolerance involves initial T cell activation, suggesting that the deficit may lie in late-acting costimulatory molecules. With this in mind we have investigated the kinetics of expression of several costimulatory pairs on DC and OVA-reactive T cells after i.v. injection of mice with peptide and LPS (immunity), or peptide alone (tolerance). We find that T cells up-regulate CD154, OX40, RANKL and PD-1 whether they are destined for tolerance or immunity, although there are some differences in the levels and length of expression. In contrast, when analyzing DC, we found that up-regulation of CD80, CD86, CD40, RANK and PDL-1 occurred only when peptide was co-administered with LPS. These data give a picture of the T cell looking for costimulatory cues that are not forthcoming when pMHC is presented by steady-state DC, leading to tolerance. However, we did see a strong and rapid up-regulation of RANKL on T cells that occurred specifically when peptide was given in the absence of LPS, suggesting a possible positive signal influencing the decision between tolerance and immunity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15756642     DOI: 10.1002/eji.200425891

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  30 in total

Review 1.  Carbohydrate-based cancer vaccines: target cancer with sugar bullets.

Authors:  Chang-Cheng Liu; Xin-Shan Ye
Journal:  Glycoconj J       Date:  2012-06-06       Impact factor: 2.916

2.  Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus.

Authors:  Delphine Pannetier; Stéphanie Reynard; Marion Russier; Alexandra Journeaux; Noël Tordo; Vincent Deubel; Sylvain Baize
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

3.  PD-1 signalling in CD4(+) T cells restrains their clonal expansion to an immunogenic stimulus, but is not critically required for peptide-induced tolerance.

Authors:  Joanne E Konkel; Friederike Frommer; Melanie D Leech; Hideo Yagita; Ari Waisman; Stephen M Anderton
Journal:  Immunology       Date:  2010-01-27       Impact factor: 7.397

4.  Changes of ribosomal protein S3 immunoreactivity and its new expression in microglia in the mice hippocampus after lipopolysaccharide treatment.

Authors:  Hui Young Lee; Joon Ha Park; Choong Hyun Lee; Bingchun Yan; Ji Hyeon Ahn; Young Joo Lee; Chan Woo Park; Jun Hwi Cho; Soo Young Choi; Moo-Ho Won
Journal:  Cell Mol Neurobiol       Date:  2012-01-25       Impact factor: 5.046

Review 5.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

6.  CD70 expression by dendritic cells plays a critical role in the immunogenicity of CD40-independent, CD4+ T cell-dependent, licensed CD8+ T cell responses.

Authors:  Katherine E Van Deusen; Rohan Rajapakse; Timothy N J Bullock
Journal:  J Leukoc Biol       Date:  2009-12-01       Impact factor: 4.962

7.  Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacity.

Authors:  Valentina Di Caro; Antonella D'Anneo; Brett Phillips; Carl Engman; Jo Harnaha; Massimo Trucco; Nick Giannoukakis
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

8.  LTβR signaling in dendritic cells induces a type I IFN response that is required for optimal clonal expansion of CD8+ T cells.

Authors:  Leslie Summers deLuca; Dennis Ng; Yunfei Gao; Michael E Wortzman; Tania H Watts; Jennifer L Gommerman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-18       Impact factor: 11.205

9.  Antigen processing and MHC-II presentation by dermal and tumor-infiltrating dendritic cells.

Authors:  Michael Y Gerner; Matthew F Mescher
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

10.  Systemic administration of lipopolysaccharide induces cyclooxygenase-2 immunoreactivity in endothelium and increases microglia in the mouse hippocampus.

Authors:  Dae Won Chung; Ki-Yeon Yoo; In Koo Hwang; Dae Won Kim; Jin Young Chung; Choong Hyun Lee; Jung Hoon Choi; Soo Young Choi; Hwa Young Youn; In Se Lee; Moo-Ho Won
Journal:  Cell Mol Neurobiol       Date:  2009-11-12       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.